Published
May 18
2026
2026
Operations · FDCA §503B · 21 CFR 211.42
The 503B Regulatory Cliff: What an Inspector Will Reconstruct After June 29.
Live
May 9
2026
2026
Editorial · 21 CFR Part 11 · FDA AI Guidance
AI will accelerate GMP operations. The reasoning behind them will not be reconstructable.
Live
May 6
2026
2026
CAPA Effectiveness · 21 CFR 820.100
The CAPA was closed. The effectiveness determination was never authorized.
Live
May 3
2026
2026
OOS Investigation · 21 CFR 211.192
The result was explained. The invalidation was never authorized.
Live
Apr 30
2026
2026
Deviation · 21 CFR 211.192
The deviation closed. The authorization question didn't.
Live
April 27
2026
2026
Deviation Root Cause · 21 CFR 211.192
The inspector doesn't ask if you found the root cause. She asks who authorized the conclusion.
Live
April 24
2026
2026
Batch Release · 21 CFR 211.192
Same atypical result. Same conclusion. One observation. One clean record.
Live